Clinical Trials Browser

Phase 1 × Melanoma × Imatinib Mesylate × Clear all

NCT01738139 2024-03-21

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Phase 1 Completed

DermatologicGastrointestinalSarcoma

Melanoma, Neoplasm Metastasis, Gastrointestinal Stromal Tumors